42 events found.
The 2nd Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy candidate. In the context of ever-increasing gene therapy clinical activity and uncertainty around immunogenicity challenges, the Gene Therapy Immunogenicity Summit will unite large pharma and innovative biotechs to ensure that you’re up to speed on […]
Translating Scientific Findings of the Skin Microbiome into Commercially Viable Therapeutics & Cosmetic Products That Improve Skin Health With improvements in the tools and technologies that enable deeper analysis of the skin microbiome, the community’s understanding of the skin microbiome is becoming clearer. This has led to the development of a number of breakthrough dermatological, […]
The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma, biotech and pioneering academics to unite under a common and ambitious goal of accelerating the practical discovery, translation, and clinical development of safe and effective treatments for prostate cancer. Here's a sneak peek of crucial topics […]
The excitement surrounding integrins has been growing over the past few years, culminating in recent clinical success, innovative biology and medicinal chemistry advancements blazing the way to tackle previously undruggable disease modalities through novel integrin targets The Integrin-Targeted Drug Discovery Summit is not just the first, but the only industry-driven event sharing pioneering advances, expert insights and exclusive updates on the field […]
New this year, the Neuropathic Pain Therapeutics digital summit is the only meeting for large pharma, biotech and pioneering academics addressing the industry’s key challenges of understanding the underlying pathophysiology of neuropathic pain, identifying novel therapeutic targets for neuropathic pain and more! With an ageing global population and unabating opioid crisis, the clinical need for […]
With 5 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years. The inaugural PI3K Pathways Summit is the industry’s only definitive conference providing in depth exploration of the biochemical basis of the pathway, the successes and […]
The 2nd Annual Biomarkers for Alzheimer’s Disease Summit is the industry’s only digital forum dedicated to sharing innovations in identifying new novel biomarkers and solving the challenges of developing clinically validated biomarkers for the earlier detection and diagnosis of Alzheimer’s Disease that are predictive of outcome measures and accurately reflect a therapeutic effect on target engagement. […]
Overcome Translational & Clinical Challenges to Develop Disease-Modifying Drugs for IPF, the Archetypal Fibrotic Disease. From Dissecting Mechanisms of Epithelial Dysfunction to Discovering Patient Reported Outcomes for More Meaningful Clinical Trials, Uncover Scientific Advancements & Actionable Insights to Optimize IPF Drug Development. Returning with a revitalized agenda including 25 brand new speakers, the hotly anticipated two-tracked […]
The CAR-TCR industry has started 2021 with a bang! With the 4th CAR-T gaining long-awaited approval, Bristol-Myers Squibb have stepped onto the commercial stage, and the CAR-TCR field continues to boom with excitement as the competition heats up. The current approved therapies have encountered significant difficulties in the commercial market. Cell Therapies come with a high […]
Recover your password.
A password will be e-mailed to you.